Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

Maravai LifeSciences Holdings, Inc. (MRVI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

5.22

+0.26

(+5.24%)

At close: 04:00PM EST

5.25

+0.03

(+0.57%)

After hours:

05:20PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	740.42M
Enterprise Value	723.34M
Trailing P/E	N/A
Forward P/E	370.37
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.55
Price/Book (mrq)	2.15
Enterprise Value/Revenue	2.61
Enterprise Value/EBITDA	1.32

Trading Information

Stock Price History

Beta (5Y Monthly)	0.02
52-Week Change ³	1.95%
S&P500 52-Week Change ³	31.18%
52 Week High ³	11.56
52 Week Low ³	4.28
50-Day Moving Average ³	7.37
200-Day Moving Average ³	8.09

Share Statistics

Avg Vol (3 month) ³	1.79M
Avg Vol (10 day) ³	2.64M
Shares Outstanding ⁵	141.84M
Implied Shares Outstanding ⁶	123.67M
Float ⁸	98.51M
% Held by Insiders ¹	1.37%
% Held by Institutions ¹	102.83%
Shares Short (Oct 31, 2024) ⁴	8.22M
Short Ratio (Oct 31, 2024) ⁴	6.63
Short % of Float (Oct 31, 2024) ⁴	6.93%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	5.81%
Shares Short (prior month Sep 30, 2024) ⁴	9.22M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-81.13%
Operating Margin (ttm)	-23.09%

Management Effectiveness

Return on Assets (ttm)	-1.61%
Return on Equity (ttm)	-42.93%

Income Statement

Revenue (ttm)	276.92M
Revenue Per Share (ttm)	2.04
Quarterly Revenue Growth (yoy)	-2.50%
Gross Profit (ttm)	N/A
EBITDA	1.04M
Net Income Avi to Common (ttm)	-224.66M
Diluted EPS (ttm)	-1.67
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	578.16M
Total Cash Per Share (mrq)	4.08
Total Debt (mrq)	613.34M
Total Debt/Equity (mrq)	100.03%
Current Ratio (mrq)	10.74
Book Value Per Share (mrq)	2.44

Cash Flow Statement

Operating Cash Flow (ttm)	29.89M
Levered Free Cash Flow (ttm)	8.86M